This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Tenet Healthcare to Divest Units for Streamlining Operations
by Zacks Equity Research
Tenet Healthcare (THC) to sell its Memphis area units for clearing its debt and focusing on core business.
HMO Industry Outlook: Multiple Levers to Drive Growth
by Sapna Bagaria
Aging U.S population, consolidation, use of technology and growing health service businesses provide ample scope for the industry to grow.
Tenet Healthcare Soars 117.1% YTD: Will Growth Continue?
by Zacks Equity Research
Tenet Healthcare's (THC) partnerships and acquisitions are likely to continue boosting its revenue base, which in turn, might perk up its share price.
Humana's (HUM) Alliances to Offer Relief to Members With CKD
by Zacks Equity Research
Humana (HUM) collaborates with Monogram Health and Somatus to provide its Humana Medicare Advantage and Commercial members, who are renal patients, with better healthcare in select geographies.
Why Should You Retain Anthem (ANTM) Stock in Your Portfolio?
by Zacks Equity Research
Riding high on a growing top line and higher membership, Anthem (ANTM) holds enough potential to reap benefits for investors.
Bull Of The Day: Select Medical Holdings (SEM)
by Brian Bolan
A recent beat and raise has propelled this stock to recent highs and could go a lot higher.
Here's Why Select Medical (SEM) Stock Looks Attractive
by Sapna Bagaria
Select Medical (SEM) benefits from revenue growth, acquisitions, and strong earnings guidance.
Ensign Group (ENSG) on Buyout Binge to Boost Capabilities
by Zacks Equity Research
Ensign Group's (ENSG) acquisition spree in Texas and Arizona will enhance its portfolio and better serve the local communities.
Here's Why Should You Hold MEDNAX (MD) in Your Portfolio
by Zacks Equity Research
Riding high on its solid top line as well as strategic buyouts, MEDNAX (MD) holds enough potential to generate returns for investors.
Centene (CNC) Divests IlliniCare as Part of Merger Agreement
by Zacks Equity Research
Centene (CNC) inks a deal to divest IlliniCare to CVS Health to facilitate the pre-announced merger agreement.
Why Should You Hold Centene (CNC) Stock in Your Portfolio?
by Zacks Equity Research
Acquisitions, rising revenues, growing membership and solid capital position carve out a long-term growth story for Centene (CNC).
Are Investors Undervaluing Select Medical (SEM) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Magellan Health's PBM Division Unveils Care Management Plan
by Zacks Equity Research
Magellan Health's (MGLN) pharmacy benefit management division's newly-launched plan is expected to drive value-added healthcare.
Humana, Epione Tie Up to Aid Medicare Advantage Members
by Zacks Equity Research
Humana (HUM) inks deal with Epione Health of Oklahoma to provide better patient care.
UnitedHealth Group to Enhance its Medicare Advantage Network
by Zacks Equity Research
UnitedHealth Group (UNH) partners Walgreens to provide better access to MA members.
Why is HCA Healthcare an Attractive Stock for Your Portfolio?
by Zacks Equity Research
Growing revenues and a strong capital position bode well for HCA Healthcare (HCA).
The Zacks Analyst Blog Highlights: Jounce Therapeutics, BioDelivery Sciences International, Ironwood Pharmaceuticals, Osmotica Pharmaceuticals and Select Medical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Jounce Therapeutics, BioDelivery Sciences International, Ironwood Pharmaceuticals, Osmotica Pharmaceuticals and Select Medical
Why Should You Hold Universal Health in Your Portfolio?
by Zacks Equity Research
Banking on its growing top line and strong segments, Universal Health (UHS) holds potential to reap benefits for investors.
Healthcare Sector Outperforming: 5 Best ETFs & Stocks QTD
by Sweta Killa
Healthcare bounced back with an outperformance starting the fourth quarter.
Humana (HUM) to Boost Medicare Advantage Network in Hawaii
by Zacks Equity Research
Humana (HUM) teams up with Hawaii Senior Medical Group to enrich patient experience of Medicare Advantage members in the region.
Humana (HUM) Scales New 52-Week High on Solid Q3 Earnings
by Zacks Equity Research
Humana (HUM) reaches a 52-week high, backed by strong-third-quarter results and Medicare business.
UnitedHealth (UNH) Looks Good: Stock Adds 5.3% in Session
by Zacks Equity Research
UnitedHealth (UNH) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
The Zacks Analyst Blog Highlights: McGrath RentCorp, FTI Consulting, Huron Consulting, Select Medical and Tenet Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: McGrath RentCorp, FTI Consulting, Huron Consulting, Select Medical and Tenet Healthcare
ISM Services Index Rebounds in October: 5 Top-Ranked Picks
by Nalak Das
The ISM Services index clearly reflects that the U.S. economy has sustained its momentum despite lingering trade conflict and global economic slowdown.
Select Medical (SEM) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Select Medical (SEM) delivered earnings and revenue surprises of 50.00% and 4.64%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?